文献速递认知障碍与痴呆帕金森病与运动障碍

特发性震颤伴痴呆患者的神经病理改变:一项尸检研究

Neuropathologic Changes in People With Essential Tremor With Dementia: A Postmortem Study.
PubMed 文献 · Neurology · 2025-10-29

该10年前瞻性队列研究对86例特发性震颤(ET)患者尸检脑组织进行神经病理评估,发现ET伴痴呆者(n=40)严重阿尔茨海默病(AD)型病理的比值比显著高于认知正常者(n=30),提示AD病理是ET痴呆的主要驱动因素。

要点

  • ET伴痴呆者严重AD型病理风险显著高于ET认知正常者。
  • ET伴轻度认知障碍者神经病理改变介于两者之间。
  • 结果提示对ET认知困难者可考虑血液生物标志物检测。

核心结论

  • 在本样本中,阿尔茨海默病病理是特发性震颤患者显著认知损害的主要驱动因素。

研究设计与样本

  • 10年前瞻性队列研究,随访认知并死亡后收集脑组织,共86例ET患者脑标本。

主要发现

  • ET痴呆组(n=40)较ET认知正常组(n=30)晚期Braak AD分期OR=22.8,Thal评分OR=8.0,CERAD评分OR=5.7,ADNC评分OR=21.1,脑淀粉样血管病评分OR=4.3,均p≤0.01。
  • ET轻度认知障碍组(n=16)神经病理改变居中,较高Braak AD分期OR=8.0,p=0.009。
  • 其他神经病理在各认知组间相似。

临床怎么用

  • 对出现认知困难的ET患者,可考虑进行血液生物标志物检测以评估AD病理。

局限性

  • 样本量有限(86例脑标本),需进一步研究阐明ET中tau聚集的性质及其与AD的异同。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Prospective cohort studies have demonstrated elevated risks of incident dementia in patients with essential tremor (ET). The explanation for this enhanced risk of dementia in ET is unknown. We aimed to elucidate the underlying neuropathologic features of ET-dementia. METHODS: In a 10-year, prospective cohort study of cognition in ET, we followed participants with detailed neuropsychological testing (assessing 5 primary domains) and assigned cognitive diagnoses (normal cognition, mild cognitive impairment [MCI], or dementia) by expert consensus; brains were collected at death. Participants resided in 43 US states. The detailed neuropathologic assessment included a Braak neurofibrillary tangle stage, Braak Lewy pathology stage, Thal β-amyloid score, and neuritic plaque score. The overall level of Alzheimer disease neuropathologic changes (ADNCs) was reported using the "ABC" scale. Other tauopathies and comorbid cerebrovascular pathologies were diagnosed. During statistical comparisons, we stratified each of the above neuropathologic features into 2 categories: high vs low. We examined how neuropathologic findings mapped onto cognitive diagnoses. RESULTS: The 381 participants yielded 86 brains (mean age at death 90.1 years, 55.8% female). Participants with ET-dementia (n = 40) had higher odds of having severe AD-type pathologies than ET-NC (n = 30): advanced Braak AD stage odds ratio (OR) = 22.8, Thal score OR = 8.0, Consortium to Establish a Registry for Alzheimer Disease score OR = 5.7, and ADNC score OR = 21.1; cerebral amyloid angiopathy scores were also higher (OR = 4.3) (all p ≤ 0.01). Participants with ET-MCI (n = 16) demonstrated intermediate neuropathology, with greater odds of higher Braak AD stages than those with ET-NC (OR = 8.0, p = 0.009). Other neuropathologies were similar across cognitive groups. DISCUSSION: Our neuropathologic description of ET-dementia shows that, in this sample of 40 participants with ET-dementia, Alzheimer pathology is the prime driver of marked cognitive impairment in ET. Further studies are needed to refine our understanding of the nature of tau aggregation in ET and the extent to which this is similar to or diverges from that seen in AD. One implication of the current finding, which is a more direct link between ET and AD, is that this opens the door to blood-based biomarker testing in individuals with ET who are experiencing cognitive difficulties.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Wainman E, Berry DS, Hernandez NC, et al. Neuropathologic Changes in People With Essential Tremor With Dementia: A Postmortem Study. Neurology. 2025. PMID: 41160795. doi:10.1212/WNL.0000000000214310

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。